285 related articles for article (PubMed ID: 30839510)
1. 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
Salah E; Bastacky SI; Jackson EK; Tofovic SP
J Cardiovasc Pharmacol; 2019 Mar; 73(3):165-177. PubMed ID: 30839510
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
3. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
5. Renovascular remodeling and renal injury after extended angiotensin II infusion.
Casare FA; Thieme K; Costa-Pessoa JM; Rossoni LV; Couto GK; Fernandes FB; Casarini DE; Oliveira-Souza M
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1295-307. PubMed ID: 26962104
[TBL] [Abstract][Full Text] [Related]
6. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
7. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
[TBL] [Abstract][Full Text] [Related]
10. Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition.
Tofovic SP; Salah EM; Dubey RK; Melhem MF; Jackson EK
J Cardiovasc Pharmacol; 2005 Jul; 46(1):25-35. PubMed ID: 15965351
[TBL] [Abstract][Full Text] [Related]
11. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
[TBL] [Abstract][Full Text] [Related]
12. Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.
Feng W; Chumley P; Hua P; Rezonzew G; Jaimes D; Duckworth MW; Xing D; Jaimes EA
Hypertension; 2012 Nov; 60(5):1226-33. PubMed ID: 22966006
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice.
Pingili AK; Davidge KN; Thirunavukkarasu S; Khan NS; Katsurada A; Majid DSA; Gonzalez FJ; Navar LG; Malik KU
Hypertension; 2017 Jun; 69(6):1104-1112. PubMed ID: 28416584
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.
Giani JF; Muñoz MC; Mayer MA; Veiras LC; Arranz C; Taira CA; Turyn D; Toblli JE; Dominici FP
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1003-13. PubMed ID: 20061544
[TBL] [Abstract][Full Text] [Related]
15. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y
Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678
[TBL] [Abstract][Full Text] [Related]
16. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
[TBL] [Abstract][Full Text] [Related]
17. 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Zhang X; Zhu H; Jackson EK; Rafikova O; Petrusevska G
Vascul Pharmacol; 2008; 48(4-6):174-83. PubMed ID: 18373958
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.
Jennings BL; Moore JA; Pingili AK; Estes AM; Fang XR; Kanu A; Gonzalez FJ; Malik KU
Am J Physiol Renal Physiol; 2015 May; 308(9):F981-92. PubMed ID: 25694484
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Beraldo JI; Benetti A; Borges-Júnior FA; Arruda-Junior DF; Martins FL; Jensen L; Dariolli R; Shimizu MH; Seguro AC; Luchi WM; Girardi ACC
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010001
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
